Reasons for Raising the Maximum Acceptable Daily Intake of EDTA and the Benefits for Iron Fortification of Foods for Children 6-24 Months of Age
Overview
Nutritional Sciences
Authors
Affiliations
The current maximum acceptable daily intake (ADI) of ethylenediaminetetraacetic acid (EDTA) of 1.9 mg day(-1) per kilogram bodyweight (mg day(-1) kgbw(-1) ) limits the daily intake of iron as iron EDTA [ferric sodium EDTA; sodium iron(III) EDTA] to approximately 2-2.5 mg day(-1) for children 6-24 months of age. This limit was defined by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) in 1973 based on data from an animal-feed study published in 1963. Other animal studies indicate that this limit can be raised to 4.4 or possibly up to 21.7 mg day(-1) kgbw(-1) , which is 2.3-11.4 times higher than the current value. For nearly 50 years, iron EDTA has been used in France in medicinal syrup for infants 1-6 months of age. The maximum recommended dosage of this drug is 37 times higher than the maximum ADI of EDTA. No adverse health effects have been reported as a result of this medicinal consumption of iron EDTA. Raising the maximum ADI of EDTA to only 4.4 mg day(-1) kgbw(-1) would enable iron EDTA, an iron fortificant with proven bioavailability in phytate-rich meals, to be added in adequate amounts to cereal-based meals for children 6-24 months of age, who are at risk of iron deficiency.
Vazdar K, Tempra C, Olzynska A, Biriukov D, Cwiklik L, Vazdar M J Phys Chem B. 2023; 127(24):5462-5469.
PMID: 37307026 PMC: 10291544. DOI: 10.1021/acs.jpcb.3c03207.
Al-Thani G, Ibrahim A, Alomairi M, Salman B, Hegazy M, Al-Harrasi A Toxics. 2023; 11(3).
PMID: 36977037 PMC: 10053313. DOI: 10.3390/toxics11030272.
Hindieh P, Yaghi J, El Khoury A, Chokr A, Atoui A, Louka N AMB Express. 2022; 12(1):128.
PMID: 36190582 PMC: 9530110. DOI: 10.1186/s13568-022-01468-w.
Ginanjar E, Indrawati L, Setianingsih I, Atmakusumah D, Harahap A, Timan I Pharmaceuticals (Basel). 2018; 11(3).
PMID: 30201907 PMC: 6161297. DOI: 10.3390/ph11030085.
Teshome E, Andango P, Osoti V, Terwel S, Otieno W, Demir A BMC Med. 2017; 15(1):89.
PMID: 28449690 PMC: 5408380. DOI: 10.1186/s12916-017-0839-z.